NASDAQ:RLAY | Cash Flow Statement | Relay Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$83.71M
2026-03-31-$73.29M-$51.11M$32.9M$138.78M
2025-12-31-$54.89M-$44.87M$1,000.00$35.46M$934,000.00
2025-09-30-$74.15M
2025-06-30-$70.38M
2025-03-31-$77.07M-$73.21M$384,000.00$42.47M
2024-12-31-$76M-$57.87M$0.00$29M$800,000.00
2024-09-30-$88.11M
2024-06-30-$92.21M
2024-03-31-$81.39M-$50.32M$1.78M$10.53M$48.92M
2023-12-31-$83.5M-$89.19M$118,000.00$59.68M$21.92M
2023-09-30-$65.73M
2023-06-30-$98.51M
2023-03-31-$94.24M-$67.13M$1.92M$75.31M$1.3M
2022-12-31-$67.5M-$57.08M$2.32M-$146.94M$1.17M
2022-09-30-$84.17M
2022-06-30-$76.79M
2022-03-31-$62.05M-$49.17M$2.79M-$112.38M$883,000.00
2021-12-31-$67.46M-$39.71M$880,000.00-$292.75M$384.01M
2021-09-30-$60.83M
2021-06-30-$193.4M
2021-03-31-$42.18M$46.64M$476,000.00-$233.62M$2.06M
2020-12-31$35.28M-$35.27M$64,000.00-$76.42M$56,000.00
2020-09-30-$36.08M
2020-06-30-$26.72M
2020-03-31-$24.89M-$22.33M$1.02M$50.37M$351,000.00
2019-12-31-$23.91M-$22.76M$598,000.00$35.9M-$227,000.00
2019-09-30-$19.67M
2019-06-30-$17.54M
2019-03-31-$14.18M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$276.48M-$235.46M$410,000.00$192.8M$1.6M
2024-12-31-$337.71M-$249.11M$2.02M-$41.08M$270.15M
2023-12-31-$341.97M-$300.32M$4.13M$257.63M$34.75M
2022-12-31-$290.51M-$229.49M$9.06M-$188.75M$289.91M
2021-12-31-$363.87M-$74.41M$3.47M-$479.51M$388.09M
2020-12-31-$52.41M-$102.49M$1.93M$81.67M$426.51M
2019-12-31-$75.31M-$66.13M$8M-$319.02M$5.61M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.